Susceptibility of in Vitro Stimulated PBMC to Infection with NSI HIV-1 Is Associated with Levels of CCR5 Expression and β-Chemokine Production
- 1 February 2000
- Vol. 267 (2) , 237-246
- https://doi.org/10.1006/viro.1999.0111
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Adaptation to Promiscuous Usage of Chemokine Receptors Is Not a Prerequisite for Human Immunodeficiency Virus Type 1 Disease ProgressionThe Journal of Infectious Diseases, 1999
- CCR5 promoter polymorphism and HIV-1 disease progressionThe Lancet, 1998
- Blockade of CC chemokine receptor 5 (CCR5)-tropic human immunodeficiency virus-1 replication in human lymphoid tissue by CC chemokines.Journal of Clinical Investigation, 1998
- Genetic polymorphism of CCR5 gene and HIV disease: The heterozygous (CCR5/Δccr5) genotype is neither essential nor sufficient for protection against disease progressionEuropean Journal of Immunology, 1997
- Phenotypic and Functional Separation of Memory and Effector Human CD8+ T CellsThe Journal of Experimental Medicine, 1997
- Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural GeneScience, 1996
- Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor geneNature, 1996
- The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 IsolatesPublished by Elsevier ,1996
- CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1Science, 1996
- Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T CellsScience, 1995